Methods for Studying Mouse and Human Invariant Natural Killer T Cells

Methods Mol Biol. 2021:2388:35-57. doi: 10.1007/978-1-0716-1775-5_4.

Abstract

Invariant natural killer T (iNKT) cells are a unique subset of T lymphocytes that recognize lipid antigens presented by nonpolymorphic major histocompatibility complex (MHC) I-like molecule CD1d. iNKT cells play essential roles in regulating immune responses against cancer, viral infection, autoimmune disease, and allergy. However, the study and application of iNKT cells have been hampered by their very small numbers (0.01-1% in mouse and human blood). Here, we describe protocols to (1) generate mouse iNKT cells from mouse mononuclear cells or from mouse hematopoietic stem cells engineered with iNKT T cell receptor (TCR) gene (denoted as mMNC-iNKT cells or mHSC-iNKT cells, respectively), (2) generate human iNKT cells from human peripheral blood mononuclear cells or from human HSC cells engineered with iNKT TCR gene (denoted as hPBMC-iNKT cells or hHSC-iNKT cells, respectively), and (3) characterize mouse and human iNKT cells in vitro and in vivo.

Keywords: Alpha-galactosylceramide (α-GalCer); CD1d; Cancer immunotherapy; Gene engineering; Glycolipid; Hematopoietic stem cell (HSC); Invariant natural killer T (iNKT) cell; T cell receptor (TCR).

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, CD1d / genetics
  • Galactosylceramides
  • Hematopoietic Stem Cells
  • Histocompatibility Antigens
  • Humans
  • Mice
  • Natural Killer T-Cells* / immunology
  • Neoplasms

Substances

  • Antigens, CD1d
  • Galactosylceramides
  • Histocompatibility Antigens